Company blamed for fueling fentanyl addiction crisis will soon sell synthetic cannabis

Notorious pharmaceutical company behind the fentanyl addiction Insys Therapeutics will soon have DEA approval to market a synthetic marijuana spray called Syndros for medical use.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
More News: Addiction | Fentanyl | Health